Hamilton Lane Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,031
| Closed | – | – | 51 |
|
|
2018
Q1 | $0 | Hold |
1,031
| – | – | ﹤0.01% | 55 |
|
|
2017
Q4 | $100K | Sell |
1,031
-1,000
| -49% | -$97K | 0.05% | 54 |
|
|
2017
Q3 | $299K | Buy |
+2,031
| New | +$299K | 0.21% | 46 |
|
|
2016
Q4 | – | Sell |
-1,388
| Closed | -$193K | – | 69 |
|
|
2016
Q3 | $193K | Buy |
+1,388
| New | +$193K | 0.1% | 58 |
|